Article
IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection.
Tissue antigens - 1 Apr 2012
Peng L J, Guo J S, Zhang Z, Shi H, Wang J, Wang J Y
Abstract excerpt
rs12979860 in interleukin 28B (IL28B) gene is associated with response to interferon-α therapy and natural viral clearance in hepatitis C. The role of this polymorphism is less known in hepatitis B virus (HBV) infection. We evaluated whether rs12979860 was associated with outcomes of HBV infection. There were 651 individuals with persistent infection (387 with liver cirrhosis, 264 without cirrhosis) and 226...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
